Guangcheng Fu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potent neutralization of Rift Valley fever virus mediated by monoclonal antibodies via concurrent inhibition of attachment and fusion.
Journal: Emerging microbes & infections
Published: February 10, 2026
Development of nanobody-based DAS-ELISA and Au nanoparticle-based immunochromatographic test strip for highly sensitive detection of Chikungunya virus.
Journal: Frontiers in immunology
Published: September 17, 2025
Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle.
Journal: International journal of molecular sciences
Published: March 10, 2025
Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV.
Journal: Viruses
Published: February 25, 2025
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques.
Journal: NPJ vaccines
Published: May 23, 2023
An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice.
Journal: Frontiers in microbiology
Published: December 02, 2022
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge.
Journal: Frontiers in immunology
Published: March 30, 2022
Preparation and biological activity analysis of chimeric antibody against capsular F1 antigen of Yersinia pestis
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: December 11, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026